Low-Volume Stock Cyclacel Shares Tick Higher Following National Institutes Of Health ClinicalTrials.gov Listing For Co.'s 'Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome,' Shows Recruiting